132 related articles for article (PubMed ID: 11147802)
1. Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: a tool for early diagnosis?
Cuda G; Gallelli A; Nisticò A; Tassone P; Barbieri V; Tagliaferri PS; Costanzo FS; Tranfa CM; Venuta S
Lung Cancer; 2000 Dec; 30(3):211-4. PubMed ID: 11147802
[No Abstract] [Full Text] [Related]
2. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U
Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
Froudarakis ME; Sourvinos G; Fournel P; Bouros D; Vergnon JM; Spandidos DA; Siafakas NM
Chest; 1998 Apr; 113(4):1091-4. PubMed ID: 9554652
[TBL] [Abstract][Full Text] [Related]
4. Waiting to exhale.
Powell CA
Am J Respir Crit Care Med; 2008 Feb; 177(3):246-7. PubMed ID: 18219056
[No Abstract] [Full Text] [Related]
5. Fractional allele loss is a valuable marker for human lung cancer detection in sputum.
Arvanitis DA; Papadakis E; Zafiropoulos A; Spandidos DA
Lung Cancer; 2003 Apr; 40(1):55-66. PubMed ID: 12660007
[TBL] [Abstract][Full Text] [Related]
6. Detection of loss of heterozygosity by high-resolution fluorescent system in non-small cell lung cancer: association of loss of heterozygosity with smoking and tumor progression.
Yoshino I; Fukuyama S; Kameyama T; Shikada Y; Oda S; Maehara Y; Sugimachi K
Chest; 2003 Feb; 123(2):545-50. PubMed ID: 12576379
[TBL] [Abstract][Full Text] [Related]
7. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A
Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633
[TBL] [Abstract][Full Text] [Related]
8. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
[TBL] [Abstract][Full Text] [Related]
9. Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients.
Sánchez-Céspedes M; Monzó M; Rosell R; Pifarré A; Calvo R; López-Cabrerizo MP; Astudillo J
Ann Oncol; 1998 Jan; 9(1):113-6. PubMed ID: 9541693
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations detected on chromosomes 13 and 14 in Chinese non-small cell lung carcinomas.
Kwong FM; Wong PS; Lung ML
Cancer Lett; 2003 Mar; 192(2):189-98. PubMed ID: 12668283
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of non-small-cell lung cancer.
Breuer RH; Postmus PE; Smit EF
Respiration; 2005; 72(3):313-30. PubMed ID: 15942304
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity on the long arm of chromosome 21 in non-small cell lung cancer.
Lee EB; Park TI; Park SH; Park JY
Ann Thorac Surg; 2003 May; 75(5):1597-600. PubMed ID: 12735585
[TBL] [Abstract][Full Text] [Related]
13. Detection of DNA abnormalities by arbitrarily primed PCR fingerprinting: allelic losses in chromosome 10q in lung cancers.
Kawakami K; Yasuda J; Shiraishi M; Kayama T; Doi K; Perucho M; Sekiya T
Biochem Biophys Res Commun; 1998 Oct; 251(1):153-7. PubMed ID: 9790923
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
15. [Liquid biopsy : A blood sample for early recognition and therapy control in lung cancer patients].
Hekmat K; Bruns C
Chirurg; 2017 Jul; 88(7):621. PubMed ID: 28616676
[No Abstract] [Full Text] [Related]
16. Allelic imbalance at the 5q14 locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs). Possible synergistic effect with p53 gene alterations on apoptosis.
Gorgoulis VG; Mariatos1 G; Manolis EN; Zacharatos P; Kotsinas A; Liloglou T; Vogiatzi T; Tsagkaraki A; Kokotas S; Tsoli E; Alchanatis M; Sfikakis PP; Asimacopoulos PJ; Field JK; Kittas C
Lung Cancer; 2000 Jun; 28(3):211-24. PubMed ID: 10812190
[TBL] [Abstract][Full Text] [Related]
17. Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
Shipman R; Schraml P; Colombi M; Ludwig CU
Int J Oncol; 1998 Jan; 12(1):107-11. PubMed ID: 9454893
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
[TBL] [Abstract][Full Text] [Related]
19. Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer.
Bruhn N; Beinert T; Oehm C; Jandrig B; Petersen I; Chen XQ; Possinger K; Fleischhacker M
Ann N Y Acad Sci; 2000 Apr; 906():72-82. PubMed ID: 10818600
[TBL] [Abstract][Full Text] [Related]
20. Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancer.
Carstensen T; Schmidt B; Engel E; Jandrig B; Witt C; Fleischhacker M
Ann N Y Acad Sci; 2004 Jun; 1022():202-10. PubMed ID: 15251961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
